GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Piotroski F-Score

Pediatrix Medical Group (Pediatrix Medical Group) Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 1959. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Pediatrix Medical Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Pediatrix Medical Group's Piotroski F-Score or its related term are showing as below:

MD' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 4

During the past 13 years, the highest Piotroski F-Score of Pediatrix Medical Group was 7. The lowest was 4. And the median was 6.


Pediatrix Medical Group Piotroski F-Score Historical Data

The historical data trend for Pediatrix Medical Group's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 6.00 6.00 4.00

Pediatrix Medical Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 7.00 6.00 4.00

Competitive Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group Piotroski F-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 14.206 + 28.282 + 21.391 + -124.287 = $-60 Mil.
Cash Flow from Operations was -100.917 + 89.054 + 79.938 + 69.25 = $137 Mil.
Revenue was 491.008 + 500.577 + 506.612 + 496.443 = $1,995 Mil.
Gross Profit was 98.053 + 115.456 + 106.889 + 101.167 = $422 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(2347.887 + 2320.051 + 2305.51 + 2326.339 + 2219.81) / 5 = $2303.9194 Mil.
Total Assets at the begining of this year (Dec22) was $2,348 Mil.
Long-Term Debt & Capital Lease Obligation was $666 Mil.
Total Current Assets was $483 Mil.
Total Current Liabilities was $389 Mil.
Net Income was -21.188 + 27.136 + 30.728 + 29.659 = $66 Mil.

Revenue was 482.229 + 486.033 + 489.915 + 513.844 = $1,972 Mil.
Gross Profit was 110.585 + 125.433 + 115.208 + 115.807 = $467 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(2722.546 + 2340.976 + 2369.616 + 2331.957 + 2347.887) / 5 = $2422.5964 Mil.
Total Assets at the begining of last year (Dec21) was $2,723 Mil.
Long-Term Debt & Capital Lease Obligation was $681 Mil.
Total Current Assets was $428 Mil.
Total Current Liabilities was $427 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Pediatrix Medical Group's current Net Income (TTM) was -60. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Pediatrix Medical Group's current Cash Flow from Operations (TTM) was 137. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-60.408/2347.887
=-0.02572867

ROA (Last Year)=Net Income/Total Assets (Dec21)
=66.335/2722.546
=0.02436506

Pediatrix Medical Group's return on assets of this year was -0.02572867. Pediatrix Medical Group's return on assets of last year was 0.02436506. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Pediatrix Medical Group's current Net Income (TTM) was -60. Pediatrix Medical Group's current Cash Flow from Operations (TTM) was 137. ==> 137 > -60 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=665.659/2303.9194
=0.2889246

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=680.594/2422.5964
=0.28093578

Pediatrix Medical Group's gearing of this year was 0.2889246. Pediatrix Medical Group's gearing of last year was 0.28093578. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=483.454/388.946
=1.24298489

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=427.989/426.983
=1.00235607

Pediatrix Medical Group's current ratio of this year was 1.24298489. Pediatrix Medical Group's current ratio of last year was 1.00235607. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Pediatrix Medical Group's number of shares in issue this year was 82.423. Pediatrix Medical Group's number of shares in issue last year was 82.021. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=421.565/1994.64
=0.21134892

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=467.033/1972.021
=0.23682963

Pediatrix Medical Group's gross margin of this year was 0.21134892. Pediatrix Medical Group's gross margin of last year was 0.23682963. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=1994.64/2347.887
=0.84954685

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=1972.021/2722.546
=0.72432973

Pediatrix Medical Group's asset turnover of this year was 0.84954685. Pediatrix Medical Group's asset turnover of last year was 0.72432973. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+1+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Pediatrix Medical Group has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Pediatrix Medical Group  (NYSE:MD) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Pediatrix Medical Group Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323

Pediatrix Medical Group (Pediatrix Medical Group) Headlines